|SUNDAY, SEPTEMBER 30|
|Welcome||Jonathan D. Linkous, Mary Ann Liebert|
|KEYNOTE: Our AI Future in Healthcare: A Physicians Perspective||Christine Cassel, MD, Professor, UCSF, former President, American Board of Internal Medicine, former President and CEO, National Quality Forum|
|4:45||6:15||NETWORKING RECEPTION (cash bar)|
|MONDAY, OCTOBER 1|
|8:30||8:45||Introduction for the Day||Jonathan D. Linkous, CEO, PATH|
|8:45||10:00||OPENING KEYNOTES: Setting the Stage|
|KEYNOTE: Tomorrow’s Healthcare Delivery System||Jay H. Sanders, M.D., FACP, FACAAI, FATA, CEO, The Global Telemedicine Group and Professor of Medicine (Adjunct) Johns Hopkins|
|KEYNOTE: The Intersection of Robotics, AI and Telehealth||Yulun Wang, Founder, Chairman and Chief Innovation Officer, InTouch Health|
|10:30||11:45||PANEL: Successful AI Applications – What Have We Learned from Imaging AI in Radiology?|
|Lessons Learned in Computer Aided Diagnosis||Seong K. Mun, PhD, Director, Arlington Innovation Center for Health Research, Virginia Tech, CEO OSEHRA|
|Computer Aided Diagnosis in Prostate MRI: Results from a Global Study||Peter Choyke, MD, Director of Molecular Imaging, National Cancer Institute, National Institutes of Health|
|Machine Learning in Feature Space – Adding New Dimensions to Imaging Research||Fred Prior, PhD, Chair of Bioinformatics, University of Arkansas|
|Artificial Intelligence in Diagnostic Imaging: Hype, Reality, and Future Directions||Eliot Siegel, MD, Vice Chair of Information Systems and Associate Vice Chair, Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine|
|11:45||1:15||BUFFET LUNCH and Exhibitor Introductions|
|1:15||2:00||PANEL: Two Perspectives on Digital Health from Two Digital Giants|
|IBM’s Priorities in the Future of Digital Health||Kyu Rhee, MD, MPP, Vice President and Chief Health Officer, IBM Corporation and IBM Watson Health|
|GE’s Priorities in the Future of Digital Health||Travis Frosch, Senior Director, Analytics, GE Healthcare|
|2:00||2:30||KEYNOTE: Updates from the National Coordinator for Health IT||Don Rucker, MD, National Coordinator for Health Information Technology,|
|3:00||3:45||PANEL: Sccessful AI Applications – Ocular Medicine|
|Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices||Michael Abràmoff, MD, President and Director, iDx, University of Iowa Hospitals and Clinics|
|Clinical Implementation Results of an AI Diabetic Retinopathy Screening System at Diabetes Care Clinics||Simon Barriga, PhD President and Chief Research Scientist, VisionQuest Biomedical|
|3:45||4:45||PANEL: Legal and Policy Issues Surrounding the Use of Advanced Technologies to Provide Healthcare Services|
|Seasoned experts in policy and legal issues surrounding the use of technology in medicine discuss where we are today, barriers we need to overcome and future prospects.||Ritika Chaturvedi, PhD, Engineer, RAND Corporation|
|Gary Capistrant, Policy Advisor, PATH|
|Bradley Merrill Thompson, JD, Member of the Firm, Epstein Becker & Green, P.C.|
|4:45||5:30||PANEL: Transforming Health Delivery through Technology Innovation in Large Health Systems|
|Building a Transformative Digital Future in Healthcare||Neil Gomes, Chief Digital Officer, Senior Vice President for Technology Innovation and Consumer Experience, Thomas Jefferson University & Jefferson Health|
|Intelligence in the Operating Room||Brian Miller, PhD, GM & SVP of Systems and Vision, Intuitive Surgical|
|TUESDAY, OCTOBER 2|
|8:30||9:00||KEYNOTE: AI And Clinical Transformation — Positive Disruption On Every Front||Molly Coye, MD, Executive in Residence, AVIA Health, Board Member Aetna|
|9:00||9:30||INVESTING IN ADVANCED HEALTHCARE TECHNOLOGY: A Perspective from Corporate Venture Capital||Oliver Keown, MD, Senior Associate Healthcare Investor at GE Ventures,|
|10:00||10:30||A GLIMPSE AT THE FUTURE: AI in Military Healthcare: Robotics Enabled Autonomous and Closed Loop Trauma Care in a Rucksack – TRACIR||Ronald Poropatich, MD, Director, Center for Military Medicine Research – University of Pittsburgh|
|10:30||11:45||PANEL: Remaining Independent – AI and Automation in Chronic Care and Home Monitoring|
|Virtual Nurse Assistants in Healthcare: How AI is Propelling the Future to Help Solve a Trillion-Dollar Problem||Wolf Shlagman, CEO, Care Angel|
|Aging in Place and Value-Based Care – Does AI Power Their Intersection?||Laura McIntosh, PhD, CEO and Founder, EmPowerYu|
|Positive Results of Artificial Intelligence that Began With Patients at Johns Hopkins University’s Copper Ridge Institute.||Daniel Pompilio, CEO, SimpleC|
|The Future Has Arrived: Continuous Vital Sign Monitoring with AI and Augmented Reality||Larry Steinberg, Cloud DX|
|11:45||12:00||WRAP-UP – Getting to the Future: Setting the Action Agenda for PATH|
Dr. Don Rucker, National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services
The Office of National Coordinator leads national health IT efforts, charged as the principal federal entity to coordinate nationwide efforts to implement and use the most advanced health information technology and the electronic exchange of health information. Previously, he was Clinical Professor of Emergency Medicine and Biomedical Informatics at Ohio State University and Chief Medical Officer at Premise Health, a worksite clinic provider. At Datamedic Corporation, Dr. Rucker co-developed the world’s first Microsoft Windows based electronic medical record. He then served as Chief Medical Officer at Siemens Healthcare USA. Dr. Rucker has served terms on the Board of Commissioners of the Certification Commission for Healthcare Information Technology and Medicare’s Evidence Development and Coverage Advisory Committee (MEDCAC) and has extensive policy experience representing healthcare innovations before Congress, MedPAC and HHS. He has practiced emergency medicine at Kaiser in California, Beth Israel Deaconess Medical Center in Boston, where he was the first full-time Emergency Department attending, the University of Pennsylvania’s Penn Presbyterian and Pennsylvania Hospitals and at Ohio State University’s Wexner Medical Center.
Dr. Molly Coye, Executive-in-Residence at AVIA and member of the Board of Directors, Aetna, Inc.
From 2010-2015, Dr. Coye served as Chief Innovation Officer for UCLA Health and head of the Institute for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. From 1999-2010 Dr. Coye was Founder and CEO of the Health Technology Center, the premier forecasting organization for emerging technologies in healthcare. She has also served as Commissioner of Health for the State of New Jersey, Director of the California Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene. An elected member of the National Academy of Medicine, Dr. Coye has been a board member of the American Hospital Association and the American Telemedicine Association and chaired the board of the American Public Health Association and of PATH, one of the largest nonprofit organizations in global health.
Ritika Chaturvedi, PhD, Engineer, RAND Corporation
Ritika Chaturvedi, an engineer at the RAND Corporation, has a diverse background in biomedical engineering, science and technology policy analysis, asset valuation, strategic consulting, and translational biomedical research. Her research focus at RAND involves understanding the implications of emerging disruptive technologies in health care (e.g., Precision Medicine, AI, CRISPR, wearable devices, genetically modified organisms, regenerative medicine technologies, hospital Internet of Things, etc.) on society (scientific and economic impact, health impact, implications on diversity and equity, implications on the labor market, security considerations, reimbursement considerations, transparency and quality control, and day-to-day workflows). Prior to joining RAND, she worked in the commercial life sciences sector, applying systems-engineering methods to strategize optimal market penetration of biotechnological assets. Chaturvedi earned a Ph.D. in bioengineering from the Tissue Microfabrication Laboratory at the University of Pennsylvania. There, her regenerative medicine based dissertation focused on understanding the structure-function relationship between vascular geometry in various organ systems by creating predefined vascular networks within engineered liver and heart tissue that were capable of sustaining function upon implantation. She also worked for several years as a health policy analyst at the Science and Technology Policy Institute (STPI) in Washington D.C., and worked closely with National Cancer Institute leadership on its Clinical Trials Working Group initiatives. At STPI, she also had a strong interest in innovation and competitiveness, and led the 5-year process evaluation of the NIH Director’s Pioneer Award.
Dr Oliver Keown, MBChB, BMedSci (Hons)
Oliver is Senior Associate of Investing and Global Development on the Healthcare Investing Team at GE Ventures. Based in Menlo Park, CA, he joined in 2016. He supports healthcare venture capital investments, deal execution and startup deal flow across digital health, healthcare IT, precision medicine & life sciences, 3D printing for health and medical device domains, while engaging in strategic international development opportunities at the intersections of venture capital, health policy and Business Innovations for GE. Previously, Oliver was Clinical Advisor and Policy Fellow at the Institute of Global Health Innovation, Imperial College London, and Clinical Advisor to the Institute’s Director, Professor the Lord Darzi of Denham. In this role, he led and advised a range of international and UK-based healthcare projects across technology, policy, parliamentary, commercial, and academic fields. His responsibilities included considerable international work in Qatar and Myanmar and liaising with the UK House of Lords. Starting his career as a junior doctor in the UK National Health Service, Oliver transitioned out of clinical practice to pursue his passion for digital health, technology and policy. While attending University and beyond, he sat as a clinical representative and committee member for the British Pharmacological Society. Oliver holds an MBChB Medicine degree (MD equivalent) and a Bachelors of Medical Science in Pharmacology from the University of Edinburgh, Scotland. He has published academic papers and editorials in The Lancet, British Medical Journal, Health Affairs and with The King’s Fund on topics spanning population health, precision medicine, antimicrobial resistance, behavioral design for smoking cessation, the economic impact of Brexit, and the diffusion of healthcare innovation across global markets.
Brian Miller, PhD, GM & SVP of Systems and Vision, Intuitive Surgical
Brian Miller, Ph.D., brings more than 20 years of robotics experience to his position as Senior Vice President and General Manager, Systems and Vision at Intuitive. He also served as Vice President, System Engineering at Intuitive, and was instrumental in the development of innovative technology, obtaining several U.S. patents. Since joining Intuitive in 2003, Dr. Miller has contributed to the design of products in the areas of surgical system networking, surgical simulation, and surgical robotic systems. He began his career in the field of robotic surgery at Computer Motion developing software for the AESOP and ZEUS surgical systems. Dr. Miller earned his B.S. in Electrical and Computer Engineering from Iowa State University followed by an M.S. in Haptic Interface and Robotics and Ph.D. in Mechanical Engineering/Robotics from Northwestern University. Dr. Miller also attended the Advanced Management Program at Harvard Business School.